VNRX

VolitionRx Limited

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$0.18

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %19.1 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.

Website

Analysis (Turkish): VNRX Hissesi Caiz mi, Helal mi? VolitionRx Limited Katılım Analizi